Eloxx Pharmaceuticals, Inc. (ELOX)
14.16
-1.68
(-10.61%)
USD |
OTCM |
Sep 03, 13:52
Eloxx Pharmaceuticals Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| June 30, 2025 | |
| September 30, 2023 | 0.233M |
| June 30, 2023 | 0.014M |
| March 31, 2023 | 0.011M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.048M |
| June 30, 2022 | -0.007M |
| March 31, 2022 | -0.011M |
| December 31, 2021 | -0.02M |
| September 30, 2021 | -0.069M |
| June 30, 2021 | 2.145M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 6.75M |
| June 30, 2020 | 11.25M |
| March 31, 2020 | 15.79M |
| December 31, 2019 | 9.079M |
| September 30, 2019 | -15.74M |
| June 30, 2019 | -26.85M |
| March 31, 2019 | -0.019M |
| December 31, 2018 | -0.179M |
| September 30, 2018 | -0.037M |
| June 30, 2018 | -0.044M |
| Date | Value |
|---|---|
| March 31, 2018 | -0.057M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.0025M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.05M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.4578M |
| March 31, 2015 | -0.186M |
| December 31, 2014 | -0.1966M |
| September 30, 2014 | -0.3348M |
| June 30, 2014 | 1.057M |
| March 31, 2014 | -0.1564M |
| December 31, 2013 | -0.1103M |
| September 30, 2013 | -0.1429M |
| June 30, 2013 | -0.1341M |
| March 31, 2013 | -0.1414M |
| December 31, 2012 | -0.1065M |
| September 30, 2012 | -0.147M |
| June 30, 2012 | -0.1068M |
| March 31, 2012 | -0.1113M |
| December 31, 2011 | -0.1036M |
| September 30, 2011 | -0.1288M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.021M |
| CorMedix, Inc. | -0.561M |
| Cannabis Global, Inc. | 0.00 |
| Breakthrough Chemistry, Inc. | 0.00 |
| BioStem Technologies, Inc. | -0.0561M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.789M |
| Cash from Financing (Quarterly) | 60.39M |
| Free Cash Flow Per Share (Quarterly) | -0.7054 |
| Free Cash Flow to Equity (Quarterly) | -4.789M |
| Free Cash Flow to Firm (Quarterly) | -4.781M |
| Free Cash Flow Yield | -35.62% |